Article
Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance.
Diabetes - 1 May 2009
Wilkes Jason J, Lloyd David J, Gekakis Nick
Abstract excerpt
OBJECTIVE: Insulin resistance develops in tandem with obesity. Ablating myostatin (Mstn) prevents obesity, so we investigated if Mstn deficiency could improve insulin sensitivity. A loss-of-function mutation (Mstn(Ln)) in either one or both alleles of the Mstn gene shows how Mstn deficiency prote...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
